Mucoactives Found to Have Little Benefit for Bronchiectasis

A new study has found that neither hypertonic saline nor carbocisteine significantly reduced the mean incidence of pulmonary exacerbations in people with bronchiectasis over 52 weeks.1

“Some current guidelines recommend mucoactive drugs plus…

Continue Reading